AI assistant
Sending…
XBiotech Inc. — Director's Dealing 2025
Nov 12, 2025
34229_dirs_2025-11-12_eb23553b-0e76-495a-b4e2-0f232c153848.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2025-10-01
Reporting Person: Rademaker Craig Evan (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-01 | Director Stock Option | $2.64 | A | 92104 | Acquired | 2035-10-01 | Common Stock (92104) | Direct |
More from XBiotech Inc.
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 29
Major Shareholding Notification
2026
Jan 23
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2025
Dec 9
Interim / Quarterly Report
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Regulatory Filings
2025
Oct 15